The life cycle of papillomaviruses is tightly linked to differentiation of host keratinocytes, but the mechanisms and cues by which life cycle events are tied to differentiation remain obscure. We have begun a systematic study of the differentiation-dependent life cycle of HPV31. A variety of signaling pathways have been implicated in controlling keratinocyte differentiation, especially the protein kinase C (PKC) pathway. We have used pharmacological inhibitors to determine that genome amplification and late transcription depend on specific PKC isoforms, and that transcription and replication are independently controlled. We found that tyrosine kinases are necessary for viral amplification but not viral transcription. These studies indicate that the PKC pathway is an important regulator of differentiation-dependent HPV31 replication and transcription.
Introduction
Human papillomaviruses are small closed-circular DNA viruses that infect the keratinocytes of stratified squamous epithelia, causing benign or malignant hyperproliferative lesions (zur Hausen, 1991 (zur Hausen, , 1996 . Over 100 types of papillomaviruses have been identified to date, infecting numerous cutaneous or mucosal sites with strong species and tissue tropism (zur Hausen, 1999) . Because of their association with malignancies including cervical cancer, certain mucosal HPV types, such as 16, 18, and 31, are of particular medical concern. HPVs are thought to gain access to the basal cells of the epithelium through small traumas (Pfister, 1990) . After a burst of DNA replication to establish a copy number of 50-200 in basal cells, the virus maintains itself in the basal layer replicating on average once per cell cycle as an episome (Flores and Lambert, 1997) . The major early promoter (p99 in HPV31) drives most viral transcription in this layer (Ozbun and Meyers, 1998b) . As the cells move from the basal into the spinous layer of the epithelium, the first step in the keratinocyte differentiation program, the intermediate phase of the viral life cycle begins. The viral late promoter (p742 in HPV31) is activated, and the viral genome amplifies to thousands of copies per cell (Flores and Lambert, 1997; Ruesch et al., 1998) . This is accompanied by an increase in transcripts for the intermediate genes, E1, E2, and E1^E4 Meyers, 1997, 1998a) . As infected cells undergo terminal differentiation in the granular and cornified layers, viral late genes, including the major and minor capsid proteins L1 and L2, are expressed and virions are assembled (Meyers et al., 1992) .
Cellular differentiation controls or influences at some level every known step of the viral life cycle including productive genome replication (Bedell et al., 1991; Flores and Lambert, 1997) , transcription (Hummel et al., 1992; Ozbun and Meyers, 1998b; Ruesch et al., 1998) , splicing (Barksdale and Baker, 1995; Ozbun and Meyers, 1997) , polyadenylation (Baker and Noe, 1989; Terhune et al., 1999 Terhune et al., , 2001 , translation (Cumming et al., 2003; Koffa et al., 2000; McPhillips et al., 2004) , virion morphogenesis (Meyers et al., 1992 , and release by desquamation (Bryan and Brown, 2001) . Arguably, even the well-studied oncogenes, whose major functions are to induce Virology 348 (2006) 328 -340 www.elsevier.com/locate/yviro sustainable DNA replication in post-mitotic cells, exist because the virus delays replication until the cells are differentiated. Keratinocyte differentiation is directed by the interplay and coordination of a variety of signaling pathways ( Fig. 1) , many of which are still poorly understood, that appear to be activated in an orderly manner as keratinocytes move through the stages of maturation (Dotto, 1999; Eckert et al., 1997a Eckert et al., , 1997b . How HPV senses, responds to, and manipulates the complex signaling environment of a differentiating keratinocyte is not known. Transcription factors regulated by differentiation, including AP-1, CDP, C/EBP, and Skn-1a (Ai et al., 1999; Andersen et al., 1997; Kyo et al., 1995; Sen et al., 2004) are known to regulate gene expression from the viral early promoter. However, the signaling pathways that are responsible for controlling HPV behavior in differentiating cells are not well understood.
Protein kinase C (PKC) is a family of signaling enzymes especially important in differentiation, and the different PKC isoforms expressed in keratinocytes appear to have distinct functions in the keratinocyte differentiation program (Denning et al., 1995b; Dlugosz and Yuspa, 1993; Ohba et al., 1998; Papp et al., 2003; Seo et al., 2004; Yang et al., 2003) . The upstream regulatory region (URR) of HPV16 can be activated by the PKC agonist TPA (Chan et al., 1990) , and AP-1, which is a wellcharacterized factor downstream of PKC, has been shown to be critical for HPV early promoter activity (Bouallaga et al., 2000; Kyo et al., 1997; Thierry et al., 1992) , although the activity of the early promoter does not change during differentiation (Ozbun and Meyers, 1998b) . PKC activation is necessary for the efficient completion of the late phase of the HPV life cycle in vitro (Meyers et al., 1992) , probably by regulating the expression of late genes via post-transcriptional mechanisms (Hummel et al., 1995; Terhune et al., 1999) . We have found that HPV31 genome amplification in the intermediate phase of the life cycle depends on PKC activity (Bodily and Meyers, 2005) .
Given the lack of information about the cues in a differentiating cell that control the HPV life cycle, we sought to better understand the role of PKC in regulating HPV31 genome amplification and p742 activation upon differentiation. We found evidence that PKCδ is involved in p742 activation, and that genome amplification requires PKCδ, α, and tyrosine phosphorylation. We also confirmed and extended our previous observation that viral genome amplification is not necessary for p742 activation (Bodily and Meyers, 2005) .
Results
Cells harboring episomally replicating HPV31 were treated with drugs and cultured under two different conditions: in monolayer culture, which models the undifferentiated basal layer of the stratified epithelium, and suspension in medium containing 1.6% methylcellulose (MC), which induces differentiation of cells at least to the spinous level and triggers both amplification of the viral genome and activation of the late promoter, p742 (Ruesch et al., 1998) . We used two cell lines in these studies: CIN-612 9E cells (9E), which were derived from Fig. 1 . Signaling pathways in keratinocytes. Drugs used in this study are indicated at their points of action in bold and italic type. a low grade lesion and maintain episomal HPV31 (Bedell et al., 1991; Rader et al., 1990) , and HFK31a:1 cells (WT:1), which were derived in the laboratory by electroporation of primary human foreskin keratinocytes with wild-type HPV31 genomic DNA and also maintain the HPV31 genome episomally (Bodily and Meyers, 2005) .
The effect of protein kinase C inhibition on viral behavior
Because of the importance of PKC in keratinocyte differentiation (Denning et al., 1995a; Lee et al., 1997; Szallasi et al., 1995; Yang et al., 2003) and because of existing evidence implicating PKC to various aspects of the HPV life cycle (Bodily and Meyers, 2005; Hummel et al., 1995; Meyers et al., 1992; Terhune et al., 1999) , we chose to test whether this family of enzymes is necessary for late promoter activation and genome amplification. Bisindolylmaleimide I, or GF109203× (GF), is a derivative of staurosporine that is specific for PKC, with IC 50 values at least an order of magnitude lower than phosphorylase kinase, the next most inhibited enzyme tested (Toullec et al., 1991) . GF inhibits all isoforms of PKC by binding the ATP binding site and is biologically active and nontoxic at concentrations around 1-5 μM (Toullec et al., 1991) . This inhibitor has become somewhat standard in studies of PKC and keratinocyte differentiation (Denning et al., 1995b; Dlugosz and Yuspa, 1994; Stanwell et al., 1996; Tibudan et al., 2002) . As reported earlier (Bodily and Meyers, 2005) , GF at 5 μM could block amplification of the HPV31 genome in 9E cells while failing to block activation of p742, providing evidence that p742 does not require amplification and that amplification requires PKC. Given this interesting observation, we thought it worthwhile to further investigate GF and its activities.
GF has been reported to block cell cycle withdrawal and expression of involucrin in primary human foreskin keratinocytes placed in suspension (Tibudan et al., 2002) . We therefore wished to determine whether GF is able to block expression of this early differentiation marker in 9E cells suspended in MC culture. As shown in Fig. 2a , suspension of 9E cells in MC increased involucrin expression, but this increase was not observed in cultures treated with 5 or 10 μM GF. Note that the involucrin expression seen in monolayer culture, which is consistent with a low level of differentiation being present in monolayer cultures , was also reduced by GF treatment. GF treatment had no effect on the expression of K14, a marker of the basal layer (data not shown). GF also had no obvious effects on the growth or morphology of cells in monolayer culture at 5 or 10 μM, although at 25 μM, the cells were somewhat spindly (data not shown). To more directly test the efficacy of GF as an inhibitor of PKC activity, we performed a kinase assay for PKCα, one of the PKC isoforms present in skin (Deucher et al., 2002) , using extracts of GFtreated or untreated 9E cells grown in monolayer or MC culture. As seen in Fig. 2b , GF was able to inhibit the kinase activity of PKCα in both monolayer and MC.
In a previous study, 5 μM GF failed to block p742 activation in MC in 9E cells (Bodily and Meyers, 2005) . In order to determine whether this effect was specific for 9E cells, we treated WT:1 cells with several concentrations of GF and measured the response of p742 and viral genome replication. Amplification of the viral genome measured by Southern blotting was clearly inhibited by GF at 5 and 10 μM, as in 9E cells (Fig. 3a; Bodily and Meyers, 2005) . Although p742 transcript levels measured by ribonuclease protection assay (RPA) were not reduced to the level seen in monolayer at either dose tested, GF was able to reduce p742 activity to significantly below that seen in untreated cells in MC (Fig. 3b) . Inhibition of p742 activation was also seen at 10 μM GF in 9E cells (data not shown). Thus, rather than being completely insensitive to GF as we previously thought, p742 seems to require PKC at some level, but p742 has a different dose response to GF as compared to amplification, consistent with the biochemical separation seen in our earlier experiments (Bodily and Meyers, 2005) . It should be noted that there was some variability from experiment to experiment in the particular dose at which GF inhibited p742 activation and between cell lines. However, GF consistently inhibited amplification at every dose tested, and the fairly high dose of 10 μM GF was usually sufficient to inhibit p742. Some variability between 9E and WT:1 cells may be attributable to differing host factors. 25 μM GF was toxic for both cell lines (data not shown).
In order to map the potential GF-repressible transcriptional element(s) in p742, we transfected several luciferase reporter plasmids into 9E cells and cultured the cells in MC, with or without 5 μM GF. The luciferase activities for each construct were measured, and the ratios of "with GF" vs. "without GF" treatment are shown in Fig. 3c . Fragment A, which includes the viral upstream regulatory region (URR), major enhancer elements, and both the early (p99) and late promoters, was repressed by GF about 50%, as was fragment H, which contains the late promoter p742 and flanking differentiation response elements. The fragment A reporter with a mutation in the TATA box of the early promoter p99 was repressed more than the wildtype fragment A, suggesting that p99 may serve to counteract the loss of activity seen with GF treatment of wild type. Fragment T, which contains the core promoter for p742 but is not activated by differentiation (Bodily and Meyers, 2005) , was completely resistant to GF treatment at this concentration. Therefore, the transcriptional elements that are repressible by GF as measured by reporter assay are located either between nucleotides 231-530 or downstream of nucleotide 680. Interestingly, these are the same regions we previously mapped as being important for activation of p742 by differentiation (Bodily and Meyers, 2005) , supporting our hypothesis that the PKC pathway contributes to the ability of p742 to respond to differentiation.
The effect of GF on the intermediate transcripts and p99
Since p742 and amplification were both effectively blocked by GF in WT:1 cells, we wished to establish a lower concentration limit for this effect and to determine whether transcripts driven by p742 are also inhibited by GF. Treating WT:1 cells in MC with a range of GF concentrations, we found an inhibitory effect of GF as low as 0.5 μM (Fig. 4a) . We expected that the intermediate transcript unit, which is immediately downstream of p742 and contains the viral replication factors E1, E2, and E4, would also be blocked by GF. Surprisingly, this was not the case, as seen in Fig. 4b , as the intensity of the E1, E2, and E4 bands were unchanged at any of the tested concentrations of GF. Note that the RNA samples analyzed in the RPA in Fig. 4b were the same samples analyzed for p742 activity in Fig. 4a in which a reduction of band intensity was seen at all concentrations. This finding was surprising given that we have assumed p742 to be the principal regulator of the levels of these transcripts. Having noticed that mutation of the p99 TATA box seemed to accentuate inhibition of fragment A activity by GF (Fig. 3c) , we wished to determine whether p99 is activated by GF. p99 transcripts in 9E cells treated with 5 μM GF and cultured in MC were increased by about 2.5-fold (Fig. 4c ). Note that p99 transcript levels are not altered by differentiation in untreated cultures, consistent with previous studies (Ozbun and Meyers, 1998b; Sen et al., 2002) . In summary, we have observed that inhibition of the PKC signaling family with GF was able to inhibit p742 and activate p99. Despite these changes in promoter activities, however, the levels of intermediate transcripts were not affected by GF treatment at the concentrations tested. These observations suggest that there may be a reciprocal or coordinated response mechanism regulating these two HPV promoters.
Inhibition of specific PKC isoforms
Finding that inhibiting PKC could block amplification and p742 activation (Figs. 3 and 4), we sought to determine which PKC isoform(s) were responsible. Keratinocytes express five PKC isoforms: PKCα, δ, ε, η, and ζ (Deucher et al., 2002; Dlugosz et al., 1992) . Of these, PKCα, δ, and η are most often implicated in regulation of differentiation (Denning et al., 1995a exist for two of them: Gö6976 (Gö) for PKCα and Rottlerin (Rott) for PKCδ. Like GF, these inhibitors have been used in several published studies of PKC isoforms in keratinocytes (Deucher et al., 2002; Efimova and Eckert, 2000; Tibudan et al., 2002) . Therefore, we treated 9E and WT:1 cells with these two compounds and examined their effects on HPV replication and promoter activation. There were no obvious effects of these agents on growth or morphology of cells in monolayer culture after 48 h in any of our experiments (not shown). Both Rott and Gö, like GF, were able to prevent amplification of HPV31 genomes in WT:1 cells MC (Fig. 5a ). Since the level of viral DNA was lower in treated MC cultures than in monolayer, PKCα and/or δ activity may also contribute to episomal maintenance. Similar results were seen with 9E cells (not shown). Treatment of cells with Hispidin, which inhibits the β isoform of PKC, which is not expressed in keratinocytes, had no effect on amplification (data not shown). We conclude from these data that activities of both PKCα and δ are needed for amplification to occur.
Using RPA analysis on RNAs from treated cells, we found that Rott modestly but consistently reduced p742 activation in MC in both 9Es and WT:1 cells (Fig. 5b and data not shown) . This suggests that the PKCδ isoform is needed for p742 activation. Note that the DNA analyzed in Fig. 5a and the RNA analyzed in Fig. 5b were from the same cultures. Thus, the fact that Gö could effectively block amplification and not p742 activation in the same culture illustrates that these two events can be separated, as we have shown before (Bodily and Meyers, 2005) . Like p742 activation, intermediate transcript expression was reduced by Rott but not Gö (Fig. 5c) . However, neither p742 nor intermediate transcript expression was reduced to the level of monolayer in WT:1 cells, suggesting that dependence on PKCδ may not be complete.
The effects of inhibitory drugs on organotypic raft cultures
Experiments discussed so far using PKC inhibitors employed 48 h of culture in MC as a model of differentiation. We wished to determine the effect of these agents on organotypic raft cultures, which sustain a more complete differentiation program and a longer time course. Raft cultures of 9E and WT:1 cells were constructed and treated for 10 days with GF, Rott, and Gö, each at 5 μM, or with C8 at 10 μM. Hematoxylin and eosin sections of 9E rafts treated for 10 days are shown in Fig. 6 ; effects on WT:1 rafts were similar (not shown). It was noted at harvest that GF-treated rafts were tougher in texture than controls. This difference was not reflected in any obvious characteristics at the morphological level, except for a slight increase in the number of large cells in the spinous and granular layers (Fig. 6b) . We noted that at 5 days of culture, GF-treated rafts were thicker and more stratified than rafts treated with E medium alone (not shown), and that primary human foreskin keratinocyte rafts treated with GF were also thicker and more stratified than controls at 10 days (not shown). That stratification could still occur in the face of PKC inhibition was surprising, given the reported importance of PKC in differentiation induced in other cell culture models (Denning et al., 1995b; Ohba et al., 1998; Seo et al., 2004; Yang et al., 2003) .
DMSO had no negative effect on differentiation of either cell line but if anything tended to increase the amount of stratification and cornification slightly in multiple images. The effect of Gö on growth and stratification of raft cultures was clearly negative (Fig. 6f) . Not only were there very few cell layers but the growth was patchy over the surface of the raft, with large areas having no growth at all. In rafts treated with Rott, large holes were seen in the tissue, some of which were bigger than whole cells, giving the tissue a "frothy" appearance (Fig. 6g) . The basis of this interesting response is unknown, but treatment for 5 days followed by 5 days of chase with E medium alone suggested that a normal basal layer could be regenerated to some extent (data not shown). It was curious that inhibiting either PKCα or δ alone should have such a profound effect on morphology but blocking all PKCs with GF did not (compare Fig. 6f and g with b) . Perhaps the individual inhibitors were more potent than GF alone and so were able to inhibit their individual isoforms more completely than GF did. Treatment with Hispidin, the PKCβ inhibitor, had no effect on growth or differentiation, having the same morphology as was seen with DMSO treatment (data not shown). In summary, inhibition of either PKCα or δ had profound effects on raft morphology, but blocking all of the PKCs with GF curiously had very little effect.
To test whether the effects of our PKC isoform inhibitors on the HPV life cycle in the differentiating environment of rafts was similar to those seen in MC culture, we extracted total DNA from WT:1 raft cultures and assayed viral replication by Southern analysis (Fig. 7a) . It was apparent that treatment with DMSO supported amplification to a high degree. Both Gö and Rott were able to inhibit replication in these cultures relative to their DMSO solvent control (Fig. 7a) . p742 activity was also enhanced slightly by treatment with DMSO, and only Rotttreated rafts showed appreciable reduction of transcript levels (Fig. 7b) . Thus, the effects of these treatments on viral transcription and replication were similar to those seen in MC. Because raft cultures are able to support high levels of L1 transcript expression and PKC has been linked to L1 expression in raft cultures (Hummel et al., 1995; Meyers et al., 1992) , we tested the effects of these PKC inhibitors on L1 transcript levels. All three PKC inhibitors were able to reduce L1 transcript levels, with GF and Rott being most effective (Fig. 7c) .
Activation of PKC
In order to efficiently produce infectious virus particles in raft cultures of 9E cells, addition of a PKC activator is necessary (Meyers et al., 1992) . The compound used in our laboratory for this purpose is C8, a synthetic diacylglycerol. It has been observed that addition of PKC activators does not lead to an increase in p742 activity in raft cultures (Hummel et al., 1995) , but C8 treatment does increase expression of L1 and L2 transcripts in raft cultures Meyers, 1997, 1998a) . Whether C8 can have an effect on replication or on p742 activity in a short-term differentiation assay in MC has not been reported. Given the observations above that PKC is necessary for amplification, we sought to test whether PKC activation by C8 would be sufficient to induce or enhance amplification in MC. C8 had no obvious effects on growth or morphology of cells in monolayer culture after 48 h of treatment (not shown). When WT:1 cells, which were apparently more sensitive to manipulation of PKC than 9E cells, were treated with C8, ethanol vehicle, or GF, we found that C8 was not sufficient to induce amplification in monolayer or enhancing amplification in MC (Fig. 8a) . (The modest increase in copy number in monolayer by treatment with GF in this experiment was not consistently seen.) C8 did not super-induce expression of L1 and L2 transcripts in monolayer or MC (Fig. 8b) , indicating that the features of raft cultures that allow enhancement of late transcript expression by C8 are not mimicked in MC. From these experiments, we conclude that PKC activation by C8 is not sufficient to induce either intermediate or late events in monolayer or MC.
Tyrosine kinases
We also wished to explore the contribution of other signaling pathways in addition to PKC. Several tyrosine phosphorylation events have been implicated in the control of differentiation, some of which are upstream or downstream of PKC (Cabodi et al., 2000; Calautti et al., 1995; Filvaroff et al., 1990) . Genistein (Gen) is a tyrosine kinase inhibitor and Fig. 6 . Morphology of 9E rafts treated with signaling inhibitors. 9E raft cultures were constructed and treated for 10 days with E medium (a), GF (b), 0.05% ethanol (c), C8 (d), 0.05% DMSO (e), Gö (f), or Rott (g). GF, Rott, and Gö were at 5 μM, and C8 was at 10 μM. Paraffin-imbedded rafts were sectioned and stained with hematoxylin and eosin. Images are at 200× magnification.
can block keratinocyte differentiation in response to calcium, confluency, or TPA (Efimova et al., 1998; Filvaroff et al., 1990; Paramio and Jorcano, 1997) . We tested the efficacy of Gen in inhibiting HPV amplification and p742 activation. As seen in Fig. 5a , Gen was as effective in inhibiting amplification as were the PKC inhibitors. It had no effect at all on p742 activation or intermediate transcript expression, however, as seen in Figs. 5b and c. This result indicates that amplification depends on tyrosine phosphorylation but p742 activation does not and shows again that amplification and p742 activation are controlled by distinguishable signaling pathways.
Discussion
Several conclusions can be drawn from the results presented here. First, PKC is clearly needed for the intermediate phase of the viral life cycle. According to our data, a component of p742 activation requires PKCδ, but viral genome amplification depends on both PKCα and δ activity as well tyrosine kinases. These observations will provide a starting point for untangling the upstream signals and downstream factors used by the virus to regulate each of these differentiation-dependent life cycle events. Second, treatment with GF, Gö, and Gen differentially affected replication and p742. In support of previous results (Bodily and Meyers, 2005) , these data form a strong body of evidence that p742 activation and replication are separable biochemically, and that late promoter activation does not depend on increased viral copy number. That we have been able to block amplification without blocking p742 and not vice versa may suggest that p742 activation itself contributes to amplification. Since the E1, E2, E4, and E5 genes are all immediately downstream of p742 and all are implicated in amplification (Fehrmann et al., 2003; Genther et al., 2003; Ozbun and Meyers, 1998a; Peh et al., 2004; Stubenrauch et al., 1998 Stubenrauch et al., , 2000 Wilson et al., 2005) , this seems a likely Fig. 7 . Effects of C8 and PKC inhibitors on HPV in raft culture. (a) Southern analysis of total DNA extracted from WT:1 rafts treated for 10 days with the indicated compounds (GF, Rott, and Gö at 5 μM; C8 at 10 μM). Total RNAs from rafts treated as in part (a) were analyzed by RPA using (b) a probe against p742 or (c) a mixture of probes against L1 and L2. A probe against cyclophilin was included as an internal control. B, digested with BamHI, which does not cut the HPV31 genome; H, digested with HindIII which digests the HPV31 genome once; Y+, yeast RNA with RNAse treatment; Y−, yeast RNA without RNAse treatment.
possibility. Third, however, as shown in Figs. 4a and b , inhibition of p742 does not necessarily result in inhibition of the E1, E2, and E4 transcripts. This was an unexpected finding and may indicate that the viral promoters are coordinately regulated to ensure proper expression of viral transcripts at the proper life cycle stage. Fourth, amplification appears to be more susceptible to manipulation than p742 activation. Indeed, only in a few cases have we observed p742 activation to be inhibited (GF, Rott), and that was not always complete or consistent from experiment to experiment. We infer that amplification requires or responds to a greater variety of input signals, or in other words, a more specific signaling environment, than does p742 activation.
It is not clear from studies by others of overexpression or inhibition of various PKC isoforms exactly what spectrum of differentiation markers each can regulate or at exactly at which stage of differentiation each operates. The PKC pathway has been best studied at the spinous-to-granular transition rather than at the basal-to-spinous transition where viral intermediate events including amplification and p742 activation occur Meyers, 1997, 1998a; Flores and Lambert, 1997; Ruesch et al., 1998) . Given the general inhibitory effects of Rott on amplification, p742 activation, and intermediate/late transcript expression (Fig. 4) , it appears that PKCδ has a necessary function in the intermediate and late stages of the viral life cycle. PKCδ in some studies has appeared to favor the expression of both spinous and granular markers, while PKCα has been found to inhibit spinous markers in favor of granular ones (Denning et al., 1995a) . Whether this is true only for the markers studied or in all models of differentiation is not known. Published studies using these inhibitors have generally used calcium-or suspension-induced differentiation as model systems, so the effects of PKC isoforms on the development of whole tissues are not well understood. We are not aware of any previous reports of these compounds being used in organotypic cultures. It is possible that the response of keratinocytes to these drugs may be different in a chronically treated, fully stratified epithelium than in a less structured cell environment and a shorter treatment regime as in MC culture or during calciuminduced differentiation.
Interestingly, DMSO alone was able to increase both amplification and p742 transcript levels in treated rafts. The basis for this effect is not known but may relate to DMSO's antioxidant activity (Macdonald et al., 2003) , which could be accentuated by the fact that raft cultures are exposed to air. It is noteworthy that viral replication and transcript levels in the small amount of material harvested from Gö treated rafts were still comparable to that seen in C8 treated cultures, despite Gö's dramatic inhibitory effect on raft tissue growth (see Fig.  6f ). The basis of the fascinating vacuolization by Rott in raft culture and inhibition of growth by Gö are not clear from histology alone. The large holes in Rott-treated tissue could relate to the known pro-apoptotic function of PKCδ (Denning et al., 1998; Li et al., 1999) , so that inhibition of this enzyme may disrupt normal cell death in the tissue. It will be important to further investigate whether and how these compounds affect the expression of differentiation-specific marker proteins. It may be, for example, that the failure of Gö-treated rafts to develop may have been due, not to toxicity, but to the removal of the inhibitory effect of PKCα on the basal-to-spinous transition (Dlugosz and Yuspa, 1993) , thereby forcing all of the cells to differentiate at once, leaving no basal layer to regenerate the tissue. This would explain how viral copy number and p742 transcription could still be fairly robust even in the face of Gö's dramatic effect on tissue growth. The data in Fig. 7c are consistent with the possibility that L1 and L2 expressions require PKCδ activity, although whether this is because p742 depends on PKCδ, or whether there are posttranscriptional mechanisms employing PKC (Hummel et al., 1995) remains to be determined.
Given that p99 has been reported to depend heavily on the activity of AP-1 (Kyo et al., 1997) , we would have expected p99 to be inhibited by GF rather than activated as we observed (Fig.  4c) . This unexpected finding deserves further investigation. Also interesting is that in the same samples that showed reduced p742 activation, the intermediate transcripts (E1/2/4) were not downregulated by GF (Fig. 4a vs. b) . This result is provocative for two reasons. First, it means that GF does not inhibit amplification through inhibition of intermediate transcripts, although whether the actual proteins are made at the same levels under these conditions is not known. Second, it suggests that p742 activation is not necessarily the only factor underlying upregulation of the intermediate transcripts during differentiation, as we have assumed. It is known that p99 can contribute to the pool of E1 and E2 transcripts Meyers, 1997, 1998a) . Perhaps activation of p99 observed in Fig. 4c is sufficient to offset inhibition of p742 so that intermediate transcript levels are kept constant. That there may be crossregulatory or feedback mechanisms in place between the promoters is interesting and remains to be investigated. Regulation of the intermediate phase of the life cycle may thus be somewhat more complicated than simply increasing the activity of p742.
The molecular mechanisms by which PKC affects amplification and late promoter activity remain to be worked out. Specifically, we do not know the relevant upstream signals that feed into the PKC pathway or the downstream targets that impinge on the virus. It is known that E1 and E2 are phosphorylated (Lentz et al., 2002; Ma et al., 1999; McBride et al., 1989) , but the functional consequences for the viral life cycle are unknown. It would be attractive to suppose that PKC could directly modify E1, thereby triggering the switch from maintenance replication to amplification. Additional signaling pathways could also be examined for their effects on HPV intermediate and late activities. It is not clear from the literature exactly which signals and factors are responsible for the earliest steps of the differentiation pathway, but Notch and c-Myc may be candidate factors at this stage (Gandarillas and Watt, 1997; Lefort and Dotto, 2004) and may also have a direct impact on p742. There is a possible binding site in the p742 region for RBP-Jκ, a Notch-responsive transcription factor, so further studies of Notch signaling in particular are warranted. We have preliminary data that inhibition of the MAPK pathways (JNK, MEK, and p38) has no significant effect on HPV intermediate events (J.M.B and C.M., unpublished observations). It is possible that redundancy between pathways could mask individual contributions. For that reason, investigation of Ras, a major node upstream of all of these pathways may be helpful, perhaps using a dominant negative strategy. Although there is evidence that contraceptive hormones are risk factors in cancer progression , the effects of hormones on HPV gene expression and replication are not clear. Reporters of the HPV18 URR can be activated by dexamethasone, but HPV31 URR reporters are activated to a much lesser degree and only under differentiating conditions ; studies on late promoters and whole genomes are lacking. The effects of physiological hormones, such as progesterone, estrogen, and androgens on the HPV life cycle have not been extensively investigated. Many other pathways or signals may also prove fruitful for further study, including retinoids, 1,25 dihydroxyvitamin D, PPAR agonists or antagonists, KGF, TGF-β, JAK/ STAT, NFκB, cyclin/CDKs, calmodulin kinase, caspase cascades, phosphatases, cholesterol sulfate and other lipid mediators, focal adhesion or desmosomal signals, and many others.
Materials and methods

Compounds
GF109203X.HCl (GF), Genistein (Gen), and Gö6976 (Gö), were obtained from Alexis Biochemicals. Hispidin was obtained from EMD Biosciences. Rottlerin (Rott) and SN-1,2-dioctanoylglycerol (C8) were obtained from Sigma. DMSO was the solvent for Gen, Gö, Rott, and Hispdin. C8 was dissolved in 100% ethanol, and GF was dissolved in water. Generally, the solvent was added directly to the shipping vial, and the suspension was agitated to dissolve the drug. All drugs were stored at −20°C in small aliquots in sterile, amber microcentrifuge tubes.
Cell culture CIN-612 9E (9E) and HFK31a:1 (WT:1) cells were maintained using standard cell culture techniques as described (Bodily and Meyers, 2005; McLaughlin-Drubin et al., 2003; Sen et al., 2002) . Cells to be treated with drugs were plated overnight at a density of 1-2 × 10 6 cells/100 mm plate. The next day, cells were trypsinized, resuspended, and cultured either in monolayer at 1 × 10 6 cells/100 mm plate or suspended at 1 × 10 6 cells/10 ml 1.6% methylcellulose (MC) to induce differentiation. Each drug was added to the final medium (monolayer or MC) before the addition of cells. Note that in this scheme, cells cultured in monolayer were exposed to the drug during attachment. The amount of drug needed for a 10 ml culture was usually diluted in 0.5 ml E medium before mixing with 10 ml E medium containing MC, thereby facilitating even distribution of the drug throughout the medium and precluding precipitation. Following 2 days of culture, cells were harvested by washing (MC) or by treatment with trypsin (monolayer), and the samples were divided for either DNA or RNA analysis. Organotypic raft cultures were prepared as described previously by construction of a collagen matrix containing fibroblasts, seeding with keratinocytes, and lifting to the air-liquid interface (Meyers, 1996; Meyers and Laimins, 1994) . Drugs were added at every feeding to the medium used to feed the rafts, and the standard culture time was 10 days.
Construction of HPV promoter reporter plasmids, including pGL2B-1706 (fragment A), pGL2B-630 (fragment H), and pGL2B-330Δ180 (fragment T), was described previously (Bodily and Meyers, 2005) . Transfection followed by differentiation by suspension MC was performed as reported previously (Bodily and Meyers, 2005; McLaughlin-Drubin et al., 2003; Sen et al., 2002) , except that cells were plated directly in KGM overnight before transfection. GF (5 μM) was added to the medium following transfection, and lysates were measured for luciferase activity as described .
Southern and ribonuclease protection analysis
Southern blotting and ribonuclease protection analysis were performed on total DNA or RNA as described previously (Bodily and Meyers, 2005; McLaughlin-Drubin et al., 2003; Sen et al., 2002) . The p742 and L1 riboprobe templates, pGem330 and pGOZ 31L1, have been described (Bodily and Meyers, 2005; Ozbun and Meyers, 1997) . Other riboprobe templates were cloned by PCR using pBSHPV31 as template: pGem930Δ700, pGemE1RPA, pGemE2/4 RPA, and pGemL2RPA for p99, E1, E2/E4, and L2 riboprobe templates, respectively. PCR primers introduced a KpnI site and a BglII site into either end of the PCR products, and the digested products were ligated into pGEM-7Zf(+) which had been digested with KpnI and BamHI. pGem930Δ700 used primers CGCGA-GATCTCTTTGCAGTAGACACAAT and CCGGGTACCA-TAATTAATTGCATATAG. pGemE1 RPA used primers CCGGGTACCCGGGGACGGGATGCAATGGTT and GCGAGATCTGCATATAGCTTTTAACCGTG. pGemE2/4 RPA used primers CCGGGTACCGGGACTGGTAAAAAA-TGGG and GCGAGATCTGTGGGTGTTTCTGTGCTCTG. This riboprobe overlaps the^E4 splice junction at HPV31 nucleotide 3295, resulting in two bands upon ribonuclease digestion, one for E2 and one for^E4. pGemL2 RPA used primers CCGGGTACCGCCCCTGATCCCGACTTTCT and GCGAGATCTGGCCCAGAAAATATGGGAAT. A probe against cyclophilin was included in each hybridization as an internal control (Steele et al., 2002) .
Western blot analysis
For Western blots, whole cell extracts were prepared by thawing cell pellets on ice and resuspending them in 250 μl of buffer A (50 mM NaPO 4 (pH 7.2), 5 mM EDTA, 50 mM NaF, 0.5 μg/ml leupeptin, 0.5 μg/ml pepstatin, 20 μg/ml aprotinin, 0.2 mM Na 3 VO 4 , 1 mM DTT, 1 mM PMSF). 250 μl of buffer B was added (identical to Buffer A but supplemented with 2% (w/v) SDS), and the samples were boiled in a water bath for 8 min, vortexing briefly every 2 min. Samples were transferred into a 1.5 ml microcentrifuge tube, and supernatants were collected after centrifugation for 5 min at room temperature. From each sample, a 500 μl aliquot of the supernatant was removed and added to 125 μl of 5× sample loading buffer (100 mM Tris, pH 8.0, 5 mM EDTA, 10% (w/v) sucrose, 2% (w/v) SDS, 33 mM DTT, and 0.1 mg/ml Pyronin Y). Protein concentrations were determined using the Lowry method as previously published (Meyers et al., 2001) . Protein extracts were applied to sodium-dodecyl sulfate (SDS)-polyacrylamide gel (acrylamide/bisacrylamide ratio, 30:0.8). A 6% gel was used to detect involucrin expression by loading 2.5 μg of total protein per sample. Proteins were transferred to nitrocellulose membrane (Protran, Schleicher and Schuell). Membranes were incubated overnight with the anti-involucrin primary antibody (Sigma (SY5)) used at 1:10,000 dilution. After being washed, the blots were incubated with anti-rabbit or antimouse horseradish peroxidase-linked secondary antibody (Amersham Life Science) as per manufacturer's instructions. The proteins were detected using enhanced chemiluminescence (ECL) method (Perkin Elmer) as per manufacturer's instructions.
Protein kinase Cα kinase assay
Protein extracts for the kinase assay were prepared by resuspending cell pellets consisting of 2 × 10 6 GF-treated and untreated cells were in 600 μl Buffer A (described above) and adding 400 μg of ice-cold acid washed glass beads (0.45 mm, Sigma). Samples were vortexed for 30 s and chilled on ice for 30 s. This cell breakage procedure was repeated a total of five times. The microfuge tubes were placed on the rim of 13 × 100 mm precooled disposable glass tubes. An 18-gauge needle was used to puncture holes through the lid and bottom of the microfuge tube. The piggy-back microfuge tube and glass tube combination was centrifuged to attain a speed of 2000 rpm. The eluted samples were transferred into new 1.5-ml microfuge tube, and supernatants were collected by centrifugation for 5 min at 4°C. Protein concentrations were measured using the Bradford assay (Bio-Rad).
Immunoprecipitation buffer consisted of 1% Triton X-100, 10 mM HEPES (pH 7.5), 2 mM EDTA, 50 mM NaF, 0.2 mM Na 3 VO 4 , 2 mM DTT, 200 mM NaCl, 20 μg/ml aprotinin, 0.5 μg/ml pepstatin, 0.5 μg/ml leupeptin, 1 mM PMSF. For each immunoprecipitation reaction, a total of between 150 and 200 μg of protein extract was used. The volume was made up to 1 ml with immunoprecipitation buffer supplemented with 2% non-fat dry milk. All samples were first precleared using 1:5000 dilution of mouse anti-cytokeratin AE1/AE3 monoclonal antibody (Chemicon International) by incubating for 1 h at 4°C with rotation. To each sample, 50 μl of preswollen Protein A Sepharose beads (Amersham Biosciences) were added and incubated at 4°C for 30 min with rotation. Beads were removed by centrifugation at 13,000 rpm for 20 s. The precleared lysates were then subjected to immunoprecipitation using 5 μl of a monoclonal antibody against PKCα (cat. #P16520, Transduction Laboratories). After addition of antibody, all samples incubated at 4°C for 1.5 h with rotation, followed by addition of 50 μl of preswollen Protein A Sepharose beads. Samples were further incubated at 4°C for 1 h with rotation. Beads were pelleted by centrifugation at 13,000 rpm for 20 s and then washed once with 500 μl ice-cold immunoprecipitation buffer without milk supplementation, and then twice in kinase buffer (20 mM HEPES, pH 7.4, 100 μM CaCl 2 , 10 mM MgCl 2 ). PKCα kinase assay was performed as previously reported (Jin et al., 2004) . Briefly, beads bound to the immunoprecipitated PKCα were suspended in 50 μl of kinase buffer supplemented with 200 μg/ml Histone H-1, 100 μM ATP, 100 μg/ml phosphatidylserine, 2 μCi of [γ -32 P] ATP, and 0.03% Triton X-100. The mixture was incubated for 30 min at 30°C. The reaction was stopped by addition of 2× SDS sample buffer and boiling the samples for 5 min. The samples were separated using 12% SDS-PAGE followed by autoradiography.
